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Abstract
The minimum information about a biofilm experiment (MIABiE) initiative has arisen
from the need to find an adequate and scientifically sound way to control the
quality of the documentation accompanying the public deposition of biofilm-related
data, particularly those obtained using high-throughput devices and techniques.
Thereby, the MIABiE consortium has initiated the identification and organization of
a set of modules containing the minimum information that needs to be reported to
guarantee the interpretability and independent verification of experimental results
and their integration with knowledge coming from other fields. MIABiE does not
intend to propose specific standards on how biofilms experiments should be
performed, because it is acknowledged that specific research questions require
specific conditions which may deviate from any standardization. Instead, MIABiE
presents guidelines about the data to be recorded and published in order for the
procedure and results to be easily and unequivocally interpreted and reproduced.
Overall, MIABiE opens up the discussion about a number of particular areas of
interest and attempts to achieve a broad consensus about which biofilm data and
metadata should be reported in scientific journals in a systematic, rigorous and
understandable manner.
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Introduction
One of the major goals of microbial systems biology is to
obtain comprehensive knowledge not only of individual cells,
but also of entire microbial communities (Zengler & Palsson,
2012). In nature, these microbial communities can mostly be
found in the form of biofilms, which are complex,
three-dimensional aggregates of microbial cells enclosed
in a self-produced polymeric matrix and living at interfaces
(Hall-Stoodley et al., 2004).
While for planktonic individual cells the emergence of
high-throughput methods and subsequent ‘omics’ disciplines
has been fast, the evolution of technologies for scrutinizing
sessile microbial communities has been slower. Nonethe-
less, similarly to what has happened in other research fields,
the field of biofilms is starting to rely heavily on high-through-
put techniques to boost the understanding of key phenom-
ena related to microbial communities (Peeters et al., 2008;
Azevedo, 2012). For instance, the development and stan-
dardization of high-throughput biofilm methods based upon
microtitre plates assays (Ceri et al., 1999; Stepanovic et al.,
2000) has paved the way for the formation of similar biofilms
in a large number of experiments. Some of these methods
have even been validated by a standard setting organization
(ASTM, 2012). Metagenomics, metaproteomics and other
‘omics’ technologies may then be applied to these structures
in order to unveil the genome, transcriptome and proteome of
the microbial community (Schmeisser et al., 2003; Ram
et al., 2005; Pepperkok & Ellenberg, 2006; Gjersing et al.,
2007; Yergeau et al., 2010). Other parameters that are
crucial for a full understanding of a spatially structured
ecosystem, such as the location of microorganisms and
matrix components, may also be assessed in a high-through-
put manner in the near future using specific microscopy
methods (Pepperkok & Ellenberg, 2006; Azevedo, 2012).
The study of biofilms is hence becoming a data-intensive
research field that must adapt to this new reality by
deploying and enforcing novel methodologies in terms of
data management and analysis. As in other areas, issues
such as lack of data reproducibility, scarcity of standardized
protocols, poor data quality and incomplete data sets
significantly hamper the quality of published results (Huang
& Gottardo, 2013). In fact, with the exception of data related
to more established techniques developed for microbial
communities as a whole (such as metagenomics), a large
volume of biofilm data from published experiments lay in the
private files of researchers. Public release of data in novel
online platforms dedicated to biofilms, such as BiofOmics
(Lourenco et al., 2012), is welcome but not sufficient. The
lack of specific details about the experimental technique(s)
employed, and the corresponding experimental conditions
will still limit data interpretability by other researchers
besides the authors (Sousa et al., 2012).
Data standardization and structuring in biofilm research is
therefore crucial to allow researchers to understand, repli-
cate and assess studies at an interlaboratory scale. This
requires the definition of the minimum information that must
be documented to ensure that an experiment on microbial
biofilms is described unambiguously and comprehensively.
Following this lead, this study presents a new standard
initiative called the minimum information about a biofilm
experiment (MIABiE), which is preparing a set of guidelines
for the documentation of biofilm experiments and data,
namely the minimum information checklists. Although the
MIABiE consortium already consists of experts with a wide
variety of research interests in biofilms, this initiative is
expected to serve as a starting point for a broader,
interdisciplinary community discussion. This concept pro-
vides a common platform which makes it easier to compare
results obtained from different environments and settings.
Benefits of MIABiE
MIABiE allows researchers to summarize the purpose,
methodology and principal conclusions of a biofilm study,
with the following primary objectives:
(1) assist authors in creating standard-compliant and struc-
tured machine-readable digital summaries of the data sets
and other outputs related to particular biofilms studies;
(2) assist authors in the process of writing comprehensive
and unambiguous reports of their research, by bringing to
their attention essential experimental details that should be
specified in their papers;
(3) facilitate the reproduction of experimental procedures,
by formulating rules and guidelines to be met by method-
ology description;
(4) enable incremental experimental designs, by using
findings from previous experiments, either to complement
or validate new results;
(5) assist reviewers of journal articles in assessing the
relevance of reported results;
(6) underpin the development of specialized bioinformatics
tools, both to produce the standard-compliant and structured
machine-readable digital summaries, and to comply with
more ambitious research goals and thus achieve a coordi-
nated understanding of microbial communities;
(7) to statistically evaluate those experimental parameters
individually and interactively that are most important in
influencing biofilm growth, development and response, and
to identify possible ‘gaps’ which can be interrogated in silico
or experimentally, allowing continual refinement of the
model.
It is important to highlight that MIABiE does not intend to
establish specific rules or provide standards on how biofilm
experiments should be performed. Instead, MIABiE provides
guidelines about the data to be recorded, considering the
purpose of the study and the devices and techniques
involved, in order for the procedure and the results to be
easily reproducible and interpretable.
The MIABiE modules
The major challenge encountered when providing guidelines
to document biofilm experiments and report their results is
the complexity and variability of biofilm studies. For
instance, studies may vary in the number and kind of
conditions tested, the wide range of microorganisms that
can be studied (both at the species and strain level), the
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inter- and intraspecies interactions these organisms may
establish in multispecies biofilms, the initial physical and
chemical conditions, the biofilm experimental model system
(s) used, the type and number of analytical methods
involved, specific data preprocessing, the number of tech-
nical and biological replicates performed, and the statistical
method(s) used to analyse the data.
To better capture such complexity and variability in biofilm
studies, the concept of module, already used for reporting
minimum information guidelines in other fields (Taylor et al.,
2007), was used. Each module addresses the standardized
collection, integration, storage and dissemination of data on
specific aspects of a biofilm study (e.g. antimicrobial suscep-
tibility testing), biofilm-related device (e.g. themicrotitre plate)
or biofilm-related technique [e.g. the crystal violet (CV)
assay]. Following an extensive discussion betweenmembers
of the biofilm community, a set of 15 modules is proposed
here.Eachmodule represents aparticular areaof interest that
critically influences the results of a biofilm experiment
(Table 1); the set of modules can be easily expanded if
necessary. The introduction and delineation of each module
was based on the following criteria: (1) all biofilm-related
experiments should comprehensively fit into one or more of
themodules; (2) asmost biofilm studies are greatly influenced
by the type of device and operation mode used to develop
them (Buckingham-Meyer et al., 2007), biofilm model sys-
tems were grouped according to their characteristics and
mode of operation; (3) the many unique parameters associ-
atedwith in vivo biofilm formation or biofilm formation on biotic
or abiotic surfaces warrant the creation of distinct modules;
and (4) techniques that are common to other research areas
should be inmodules of their own, delegating their description
to the minimum information guidelines established by the
corresponding initiative.
As shown in Fig. 1, the modular approach is quite flexible,
that is, as new devices, techniques or applications become
increasingly popular, a new module can be created and
integrated in this list without affecting the guidelines already
in use in other modules. In fact, novel research questions
often require modifying the published protocols and meth-
ods to achieve relevant answers. It is important that the
modifications to the published methods be clearly docu-
mented to understand how the method itself evolves with
the research data and knowledge gained.
A second major advantage is the delegation of respon-
sibility, that is, the MIABiE consortium is focused on
biofilm-specific data issues, relying on the guidelines of
other consortia to link to other research areas.
Integration of MIABiE with other minimum
information guidelines
As already mentioned, biofilm research is built upon
biofilm-specific experiments and experiments from other
scientific areas. To address this interrelation, MIABiE has
engaged MIBBI (http://www.mibbi.org/), an initiative that
provides a common portal with minimum information check-
lists, standards and guidelines from all areas of biological
and biomedical sciences (Taylor et al., 2008).
At the core of the MIABiE strategy is the delegation of the
documentation guidelines of non-biofilm-specific data. For
instance, data coming from transcriptome, proteome and
other ‘omic’ technologies applied to biofilm populations
should be documented as suggested by MIAME (Brazma
et al., 2001), MIAPE (Taylor et al., 2007) and similar
guidelines (Fig. 2a). This would also be the case for specific
techniques, such as fluorescence in situ hybridization or flow
cytometry, for which minimum information guidelines have
also been reported (Deutsch et al., 2008; Lee et al., 2008).
Availability of biofilm-centered databases and
portals
For many years, the main source of biofilm information has
been the scientific literature. This is hardly an optimal
solution as manual curation of scientific literature is
resource- and time-consuming (Lok, 2010; Lu & Hirschman,
2012). Far more important, biofilm-related publications do
not usually have experimental or analytical raw data
attached, which hampers attempts to reproduce certain
experiments.
A strong indication that this situation is about to change is
the emergence of databases and other public websites
where data on biofilm experiments are made readily
available (Inst. Pasteur, 2013; NASA, 2013; Proteome
commons, 2013). Since 2012, the BiofOmics Web database
offers a public site for experimental data and results from
biofilm experiments (Lourenco et al., 2012). BiofOmics
developers have committed to a trade-off between MIABiE
guidelines and the donation of data, and data submitters are
encouraged to comply with MIABiE guidelines, by creating a
standardized Excel data workbook.
Although the BiofOmics platform can be extended to
accommodate more data, the idea is not to cover all data,
especially if they are not specific to biofilm experiments
(Fig. 2b). Most of the results generated by Module 12, for
instance, will be stored in ‘omics’ databases, such as the
Gene Expression Omnibus (GEO) database (Edgar et al.,
2002) and the PRoteomics IDEntifications (PRIDE) data-
base (Wang et al., 2012), which keep data on the transcrip-
tome and proteome of organisms, respectively. The use of
these resources, rather than creating specialized ones, has
two main advantages: it alleviates biofilm-centered data-
bases of the burden of duplicating the storage of such large
data volumes, while relying on the documentation guidelines
established by ‘omics’ experts.
Use and creation of vocabularies and
terminology standardization
MIABiE enforces the use of controlled vocabularies that
facilitate the transmission of information, in terms of com-
prehensibility and interpretation. Ambiguity as the field
develops its own terminology can occur not only within the
field but also between different fields. For example, the term
‘extracellular matrix’ (ECM) has been used in plant and
animal biology to refer to extracellular materials which may
have a structural role (e.g. connective), but has been
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Table 1 Description of the modules proposed by MIABiE
Module Short description
1. Sample generation and study design The description of the goal(s) and design of the experiment. This includes the identification of
microorganisms (to the strain level, preferably with an identifier linking to an international Biological
Resource Center) and environmental conditions tested, as well as the technologies used to form and
analyse the biofilm
2. Naturally occurring biofilms Refers to biofilms formed previously in real settings such as in the environment (e.g. streams, rocks, soil,
buildings), industry (e.g. process equipment and piping) and living beings (e.g. animals, humans,
plants). It describes as extensively as possible the conditions under which the biofilm was formed,
before sampling was carried out, or in situ examination
3. Single- and multiwell reactors Specifies the type(s) of well reactors used to develop biofilms in a standardized manner, together
with process variables. Examples of such reactors are the microtitre plates (or 6/24/96-well tissue
culture plates), the MatTek plates and the MBECTMdevice
4. Continuously stirred flow reactors Covers the use of stirred reactors with a continuous flow of media for biofilm formation and growth, and the
documentation of process variables in in vitro biofilm development (temperature, pressure, residence
time, flow rate, nutrient concentration and type, etc.). Examples of stirred flow reactors are the
chemostat, annular reactors, CDC biofilm reactor, rotating disc reactor.
5. Continuous plug flow reactors Describes the various types of reactors that work in the continuous mode of operation (except for
multiwells and stirred reactors) and associated process variables. Reactors included in this module are
the modified Robbins device (MRD), flow cells, drip flow reactors, tubing reactors and microfluidic
systems
6. In vivo biofilm models Provides protocols to study biofilm formation and development in in vivo animal models. Additionally,
experimenters should inform about the device (catheter, beads, etc.) (if any) that is used to promote the
growth of biofilms, providing information on the constituent material/biomaterial, eventual pre-and
postprocessing of the material and the conditions used for biofilm growth, anatomical compartment of
infection, infection procedure, recalcitrance to antimicrobial therapy, length of time of infection, and
animal species and strain
7. In vitro or ex vivo biofilm
formation on biotic
surfaces
Describes the protocols for biofilm formation in animal and vegetable tissue models. Experimenters
should indicate the tissues (e.g. wound biofilm model, RHE model ), the medium and the conditions
used for developing biofilm on these surfaces
8. Determination of antimicrobial
susceptibility
Describes protocols to evaluate the activity of antimicrobial products (including antibiotics and
disinfectants) against biofilms. This includes the parameters related with the antimicrobial agent(s)
(name, company, dose, etc.), the preprocessing of antimicrobials (preparation of stock solutions,
storage, etc.), the neutralization of the active component and protocols for susceptibility testing
including pharmacokinetic [e.g. antibiotic concentrations (constant or fluctuating), exposure time] and
the pharmacodynamic parameters (e.g. viability, resistance development, biomass, biofilm structure)
and endpoints (e.g. minimum inhibitory, bactericidal or eradication concentrations). Information
about removal and/or neutralization of the antimicrobial agents prior to downstream experiments
should also be provided. Likewise, authors should describe the automation conditions of
high-throughput screening campaigns, for example liquid-handling workstations and robotic protocols
9. Culture-based biofilm
assessment
Covers all the procedures related to CFU quantification and colony morphology classification in biofilms.
These include details on sonication or scraping to remove the adhered cells, homogenization of the
suspended cells (e.g. by vortexing), the type of plating medium used, incubation conditions, etc.
10. Non-culture-based biofilm
assessment
Characterizes other analytical techniques that are applied to biofilm samples prior to the final analysis,
such as 4’,6-diamidino-2-phenylindole (DAPI), crystal violet (CV), Live/Dead, fluorescence in situ
hybridization (FISH) and Dubois. Details on the technique include the final purpose of the technique,
any reaction or interactions associated with the technique and any pretreatment of the sample
11. Microscopy and flow
cytometry methods
This module is specialized in flow cytometry and the different types of microscopy methods (such as CSLM)
used in support of the analytical techniques, such as DAPI, Live/Dead, FISH, colony morphology.
12. Spectrophotometric
detection methods
Optical detection is used to support analytical techniques, such as CV,
2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT), Alamar Blue
(resazurin), ATP detection and the Lowry protein assay, whose final values are dependent on
absorbance, bioluminescence or fluorescence data. Data on the type of equipment used and
wavelength(s) employed among other characteristics should be indicated
13. ‘Omics’ and molecular methods Encompasses the documentation of methods that evaluate and quantify the presence of molecules in
biofilms (e.g. PCR) and the application of ‘omics’ methods such as proteomics, transcriptomics and
metabolomics and their meta-version. MIABiE guidelines are compliant with guidelines for
microarray-based transcriptomics (MIAME), quantitative real-time PCR (MIQE), proteomics (MIAPE) and
metabolomics (CIMR), and will embrace any forthcoming guidelines emerging from other relevant ‘omics’
communities
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gaining use by biofilm researchers where it has been
replacing what was previously known as ‘extracellular
polysaccharides’ or more generically, as the complexities
of the biofilm matrix have been revealed, ‘extracellular
polymeric substances’ (EPS) (Flemming & Wingender,
2010). The use of ‘matrix’ to discuss the biofilm EPS has
caused confusion, particularly when the biofilm might be
investigated in clinical specimens where it is not clear
whether ECM refers to the host or microbial derived
fractions. Another term which can result in ambiguity is
‘substrate’. In some cases, this term is used, more in the
engineering community, to refer to the surface that biofilms
are grown on, while the more common usage is as a nutrient.
Regarding the data documenting a biofilm experiment,
MIABiE has already looked into existing vocabularies. For
instance, microorganisms and their sequences are cata-
logued in NCBI Taxonomy and GenBank (NCBI Resource
Coordinators, 2013), strain numbers in international culture
collections can be found in Straininfo.net (Dawyndt et al.,
2005), and metabolism is described in pathway databases
such as KEGG (Kanehisa et al., 2012) and BioCyc (Caspi
et al., 2012). By cross-linking to these databases, research-
ers obviate the need to include this sort of data on their
experiment files.
Portals such as the Open Biological and Biomedical
Ontologies (OBO) foundry (http://www.obofoundry.org/)
congregate a number of biological vocabularies potentially
useful in biofilm descriptions (Ceusters & Smith, 2010). For
instance, the PATO ontology (Beck et al., 2009), which
describes phenotypic qualities generically, could be adapted
or extended to include qualities specific of microbial com-
munities. Likewise, systems biology approaches could
benefit greatly from the efforts of Gene Ontology Consor-
tium to annotate various biofilm aspects (Gene Ontology
Consortium, 2013). Moreover, dictionaries on nonspecific
information could be derived from databases and associated
terminologies. For example, antimicrobial products, such as
drugs and natural peptides, are being catalogued in Drug-
Bank (Knox et al., 2011) and the Collection of Anti-Microbial
Peptides (CAMP) (Thomas et al., 2010), respectively.
Table 1 (continued)
Module Short description
14. Statistical assessment The statistical evaluation of the data should be fully disclosed and should include the type of test, whether
or not data were transformed, significance levels used, etc. The ability to reproduce the experiment in
other laboratory and obtain similar results is critical
15. Bioinformatics resources and tools Underpins data standardization and data interchange infrastructures, and the development of
bioinformatics software specialized in biofilms data management and data analytics. This includes, among
others: standardized terminologies specialized in biofilms, markup languages delivering
computer-readable formats for representing biofilm models (e.g. similar to the systems biology markup
language), databases to deposit biofilm data publicly, software for biofilm image analysis, and tools for
drug virtual screening, and biofilm modelling and simulation
Fig. 1 Schematic representation of the modules proposed by MIABiE.
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Vocabularies on biofilm specifics such as devices, tech-
niques, materials and media are not available. Similarly, the
qualitative description of biofilm features and behaviour,
namely the morphology of the colonies when facing partic-
ular stresses, was subjective. Given their critical role in the
description of the experiment, MIABiE initiated the elabora-
tion of vocabularies covering these aspects, once again
reaching out to the community for a consensus.
Final remarks
Similarly to what happened in other fields of Biology, the
study of biofilms has entered the high-throughput era.
Because data and knowledge accumulate rapidly, it is
crucial to empower researchers with instant access to this
information. New studies could be justified, integrated or
contextualized by previous knowledge by comparing results
from multiple, expected to be similar, experiments. Thereby,
it seems only logical that to pursue high-quality research,
biofilm experts engage into systematic data management
and interchange.
Consequently, MIABiE proposes a standards initiative that
intends to simplify the exchanging and comparison of biofilm
data across different laboratories, by ensuring that authors
document their experiments comprehensively and unequiv-
ocally in scientific publications. MIABiE also aims at comple-
menting existing minimum information guidelines for other
high-throughput fields, to assist in the completeness of data
provided for a study. For instance, if an experiment on
proteomics is carried out on biofilms, the data on proteomics
might become less meaningful if the characterization of the
microbiological sample is not complete. By providing ade-
quate background to the microbiological sample, MIABiE
ensures that results from such experiments can be better
interpreted in the future.
Finally, MIABiE attempts to decrease the variability of
results obtained frombiofilmstudies.Over time, this variability
has become accepted as some sort of inevitability. While it is
unlikely that this initiative will reduce variability to the level
observed for individual cells, it will allow source discrimination
into experimental variations, and intrinsic and extrinsic noise
due to themicroorganisms (Elowitzet al., 2002). This ability is
important to assess the disparity of results obtained by
different laboratories applying biofilm-related technologies
under similar conditions, as well as to perform head-to-head
comparisons between some of the most commonly used
technologies, for example CV and XTT.
The success of MIABiE initiative depends on establishing
a consensus within the biofilm community. At the moment,
MIABiE modules and reporting requirements are being
identified by the MIABiE consortium, but a broader commu-
nity discussion should be pursued continuously. This
discussion will be conducted either through e-mail discus-
sion lists (details on the website, http://www.miabie.org) or
on speciality conferences on biofilms. The first of these
conference discussions was held at the Eurobiofilms 2013
meeting in Ghent, Belgium (9–12 September 2013).
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